Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 227

1.

Metformin plus chemotherapy versus chemotherapy alone in the first-line treatment of HER2-negative metastatic breast cancer. The MYME randomized, phase 2 clinical trial.

Nanni O, Amadori D, De Censi A, Rocca A, Freschi A, Bologna A, Gianni L, Rosetti F, Amaducci L, Cavanna L, Foca F, Sarti S, Serra P, Valmorri L, Bruzzi P, Corradengo D, Gennari A; MYME investigators.

Breast Cancer Res Treat. 2018 Dec 7. doi: 10.1007/s10549-018-05070-2. [Epub ahead of print]

PMID:
30536182
2.

Nine weeks versus 1 year adjuvant trastuzumab in combination with chemotherapy: final results of the phase III randomized Short-HER study‡.

Conte P, Frassoldati A, Bisagni G, Brandes AA, Donadio M, Garrone O, Piacentini F, Cavanna L, Giotta F, Aieta M, Gebbia V, Molino A, Musolino A, Ferro A, Maltoni R, Danese S, Zamagni C, Rimanti A, Cagossi K, Russo A, Pronzato P, Giovanardi F, Moretti G, Lombardo L, Schirone A, Beano A, Amaducci L, Bajardi EA, Vicini R, Balduzzi S, D'Amico R, Guarneri V; Reader study level-I and level-II Groups .

Ann Oncol. 2018 Dec 1;29(12):2328-2333. doi: 10.1093/annonc/mdy414.

PMID:
30219886
3.

Correction: The Promher Study: An Observational Italian Study on Adjuvant Therapy for HER2-Positive, pT1a-b pN0 Breast Cancer.

Gori S, Inno A, Fiorio E, Foglietta J, Ferro A, Gulisano M, Pinotti G, Gubiotti M, Cavazzini MG, Turazza M, Duranti S, De Simone V, Iezzi L, Bisagni G, Spazzapan S, Cavanna L, Saggia C, Bria E, Cretella E, Vici P, Santini D, Fabi A, Garrone O, Frassoldati A, Amaducci L, Saracchini S, Evangelisti L, Barni S, Gamucci T, Mentuccia L, Laudadio L, Zoboli A, Marchetti F, Bogina G, Lunardi G, Boni L.

PLoS One. 2015 Sep 25;10(9):e0139650. doi: 10.1371/journal.pone.0139650. eCollection 2015. No abstract available.

4.

The Promher Study: An Observational Italian Study on Adjuvant Therapy for HER2-Positive, pT1a-b pN0 Breast Cancer.

Gori S, Inno A, Fiorio E, Foglietta J, Ferro A, Gulisano M, Pinotti G, Gubiotti M, Cavazzini MG, Turazza M, Duranti S, De Simone V, Iezzi L, Bisagni G, Spazzapan S, Cavanna L, Saggia C, Bria E, Cretella E, Vici P, Santini D, Fabi A, Garrone O, Frassoldati A, Amaducci L, Saracchini S, Evangelisti L, Barni S, Gamucci T, Mentuccia L, Laudadio L, Zoboli A, Marchetti F, Bogina G, Lunardi G, Boni L.

PLoS One. 2015 Sep 4;10(9):e0136731. doi: 10.1371/journal.pone.0136731. eCollection 2015. Erratum in: PLoS One. 2015;10(9):e0139650.

5.

Time to initiation of adjuvant chemotherapy in patients with rapidly proliferating early breast cancer.

Farolfi A, Scarpi E, Rocca A, Mangia A, Biglia N, Gianni L, Tienghi A, Valerio MR, Gasparini G, Amaducci L, Faedi M, Baldini E, Rubagotti A, Maltoni R, Paradiso A, Amadori D.

Eur J Cancer. 2015 Sep;51(14):1874-81. doi: 10.1016/j.ejca.2015.07.003. Epub 2015 Jul 20.

PMID:
26206258
6.

Randomized phase III trial of adjuvant epirubicin followed by cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) versus CMF followed by epirubicin in patients with node-negative or 1-3 node-positive rapidly proliferating breast cancer.

Amadori D, Silvestrini R, De Lena M, Boccardo F, Rocca A, Scarpi E, Schittulli F, Brandi M, Maltoni R, Serra P, Ponzone R, Biglia N, Gianni L, Tienghi A, Valerio MR, Bonginelli P, Amaducci L, Faedi M, Baldini E, Paradiso A.

Breast Cancer Res Treat. 2011 Feb;125(3):775-84. doi: 10.1007/s10549-010-1257-5. Epub 2010 Dec 4.

7.

Efficacy of azathioprine on multiple sclerosis new brain lesions evaluated using magnetic resonance imaging.

Massacesi L, Parigi A, Barilaro A, Repice AM, Pellicanò G, Konze A, Siracusa G, Taiuti R, Amaducci L.

Arch Neurol. 2005 Dec;62(12):1843-7.

PMID:
16344342
8.

Temozolomide and interferon-alpha in metastatic melanoma: a phase II study of the Italian Melanoma Intergroup.

Ridolfi R, Romanini A, Sileni VC, Michiara M, Guida M, Biasco G, Poletti P, Amaducci L, Leoni M, Ravaioli A.

Melanoma Res. 2004 Aug;14(4):295-9.

PMID:
15305161
9.

Epidemiology of dementias.

Baldereschi M, Di Carlo A, Amaducci L.

Drugs Today (Barc). 1998 Sep;34(9):747-58.

PMID:
14988751
10.

Lifestyle-related risk factors for Parkinson's disease: a population-based study.

Baldereschi M, Di Carlo A, Vanni P, Ghetti A, Carbonin P, Amaducci L, Inzitari D; Italian Longitudinal Study on Aging Working Group.

Acta Neurol Scand. 2003 Oct;108(4):239-44.

PMID:
12956856
11.

Stroke in an elderly population: incidence and impact on survival and daily function. The Italian Longitudinal Study on Aging.

Di Carlo A, Baldereschi M, Gandolfo C, Candelise L, Ghetti A, Maggi S, Scafato E, Carbonin P, Amaducci L, Inzitari D; ILSA Working Group.

Cerebrovasc Dis. 2003;16(2):141-50.

PMID:
12792172
12.

Incidence of dementia, Alzheimer's disease, and vascular dementia in Italy. The ILSA Study.

Di Carlo A, Baldereschi M, Amaducci L, Lepore V, Bracco L, Maggi S, Bonaiuto S, Perissinotto E, Scarlato G, Farchi G, Inzitari D; ILSA Working Group.

J Am Geriatr Soc. 2002 Jan;50(1):41-8.

PMID:
12028245
13.

Maurice Ravel and right-hemisphere musical creativity: influence of disease on his last musical works?

Amaducci L, Grassi E, Boller F.

Eur J Neurol. 2002 Jan;9(1):75-82.

PMID:
11784380
14.

Parkinson's disease and parkinsonism in a longitudinal study: two-fold higher incidence in men. ILSA Working Group. Italian Longitudinal Study on Aging.

Baldereschi M, Di Carlo A, Rocca WA, Vanni P, Maggi S, Perissinotto E, Grigoletto F, Amaducci L, Inzitari D.

Neurology. 2000 Nov 14;55(9):1358-63.

PMID:
11087781
15.

Cognitive impairment without dementia in older people: prevalence, vascular risk factors, impact on disability. The Italian Longitudinal Study on Aging.

Di Carlo A, Baldereschi M, Amaducci L, Maggi S, Grigoletto F, Scarlato G, Inzitari D.

J Am Geriatr Soc. 2000 Jul;48(7):775-82.

PMID:
10894316
16.

Cognitive impairment in multiple sclerosis: a longitudinal study.

Amato MP, Ponziani G, Amaducci L.

Electroencephalogr Clin Neurophysiol Suppl. 1999;50:465-8. No abstract available.

PMID:
10689495
17.

Magnetic resonance measures in Alzheimer disease: their utility in early diagnosis and evaluating disease progression.

Bracco L, Piccini C, Manfredi G, Fonda C, Falcini M, Amaducci L.

Alzheimer Dis Assoc Disord. 1999 Jul-Sep;13(3):157-64.

PMID:
10485575
18.

Influence of different screening procedures on the stroke prevalence estimates: the Italian Longitudinal Study on Aging.

Di Carlo A, Candelise L, Gandolfo C, Grigoletto F, Volonnino G, Baldereschi M, Maggi S, Scarlato G, Amaducci L, Inzitari D.

Cerebrovasc Dis. 1999 Jul-Aug;9(4):231-7.

PMID:
10393411
19.

Validity of different linguistic versions of the Alzheimer's Disease Assessment Scale in an international multicentre Alzheimer's disease trial.

Inzitari D, Rossi R, Lamassa M, Mugnai S, Carlucci G, Bianchi C, Amaducci L.

Dement Geriatr Cogn Disord. 1999 Jul-Aug;10(4):269-77.

PMID:
10364644
20.

Dementia is a major predictor of death among the Italian elderly. ILSA Working Group. Italian Longitudinal Study on Aging.

Baldereschi M, Di Carlo A, Maggi S, Grigoletto F, Scarlato G, Amaducci L, Inzitari D.

Neurology. 1999 Mar 10;52(4):709-13.

PMID:
10078714
21.

Rates and risk factors for dementia and Alzheimer's disease: results from EURODEM pooled analyses. EURODEM Incidence Research Group and Work Groups. European Studies of Dementia.

Launer LJ, Andersen K, Dewey ME, Letenneur L, Ott A, Amaducci LA, Brayne C, Copeland JR, Dartigues JF, Kragh-Sorensen P, Lobo A, Martinez-Lage JM, Stijnen T, Hofman A.

Neurology. 1999 Jan 1;52(1):78-84.

PMID:
9921852
22.

Rate of progression of mental decline in Alzheimer disease: summary of European studies.

Bracco L, Piccini C, Amaducci L.

Alzheimer Dis Assoc Disord. 1998 Dec;12(4):347-55. Review.

PMID:
9876964
23.

Education and the risk of physical disability and mortality among men and women aged 65 to 84: the Italian Longitudinal Study on Aging.

Amaducci L, Maggi S, Langlois J, Minicuci N, Baldereschi M, Di Carlo A, Grigoletto F.

J Gerontol A Biol Sci Med Sci. 1998 Nov;53(6):M484-90.

PMID:
9823754
24.

Detection of skewed T-cell receptor V-beta gene usage in the peripheral blood of patients with multiple sclerosis.

Gran B, Gestri D, Sottini A, Quiròs Roldàn E, Bettinardi A, Signorini S, Primi D, Ballerini C, Taiuti R, Amaducci L, Massacesi L.

J Neuroimmunol. 1998 May 1;85(1):22-32.

PMID:
9626994
25.

Sex-related differences in human cerebral hemodynamics.

Marinoni M, Ginanneschi A, Inzitari D, Mugnai S, Amaducci L.

Acta Neurol Scand. 1998 May;97(5):324-7.

PMID:
9613563
26.

No implication of apolipoprotein E polymorphism in Italian schizophrenic patients.

Sorbi S, Nacmias B, Tedde A, Latorraca S, Forleo P, Guarnieri BM, Petruzzi C, Daneluzzo E, Ortenzi L, Piacentini S, Amaducci L.

Neurosci Lett. 1998 Mar 13;244(2):118-20.

PMID:
9572600
27.

Implication of alpha1-antichymotrypsin polymorphism in familial Alzheimer's disease.

Nacmias B, Marcon G, Tedde A, Forleo P, Latorraca S, Piacentini S, Amaducci L, Sorbi S.

Neurosci Lett. 1998 Mar 13;244(2):85-8.

PMID:
9572591
28.

Estrogen-replacement therapy and Alzheimer's disease in the Italian Longitudinal Study on Aging.

Baldereschi M, Di Carlo A, Lepore V, Bracco L, Maggi S, Grigoletto F, Scarlato G, Amaducci L.

Neurology. 1998 Apr;50(4):996-1002.

PMID:
9566385
29.

Alzheimer's disease: patterns of cognitive impairment at different levels of disease severity.

Piccini C, Pecori D, Campani D, Falcini M, Piccininni M, Manfredi G, Amaducci L, Bracco L.

J Neurol Sci. 1998;156(1):59-64.

PMID:
9559988
30.

Human studies: the longitudinal approach.

Di Carlo A, Baldereschi M, Maggi S, Amaducci L.

Aging (Milano). 1997 Dec;9(6):442-3. Review. No abstract available.

PMID:
9553633
31.

Growth properties and growth factor responsiveness in skin fibroblasts from centenarians.

Tesco G, Vergelli M, Grassilli E, Salomoni P, Bellesia E, Sikora E, Radziszewska E, Barbieri D, Latorraca S, Fagiolo U, Santacaterina S, Amaducci L, Tiozzo R, Franceschi C, Sorbi S.

Biochem Biophys Res Commun. 1998 Mar 27;244(3):912-6.

PMID:
9535767
32.

T-cell response to myelin basic protein and lipid-bound myelin basic protein in patients with multiple sclerosis and healthy donors.

Mazzanti B, Vergelli M, Riccio P, Martin R, McFarland HF, Liuzzi GM, Amaducci L, Massacesi L.

J Neuroimmunol. 1998 Feb;82(1):96-100.

PMID:
9526851
33.

Treatable and reversible dementias: an update.

Piccini C, Bracco L, Amaducci L.

J Neurol Sci. 1998 Jan 8;153(2):172-81. Review.

PMID:
9511876
34.

Immunosuppressive activity of 13-cis-retinoic acid in rats: aspects of pharmacokinetics and pharmacodynamics.

Vergelli M, Olivotto J, Castigli E, Gran B, Raimondi L, Pirisino R, Amaducci L, Massacesi L.

Immunopharmacology. 1997 Oct;37(2-3):191-7.

PMID:
9403338
35.

Evaluation of the cost of home care for terminally ill cancer patients.

Maltoni M, Travaglini C, Santi M, Nanni O, Scarpi E, Benvenuti S, Albertazzi L, Amaducci L, Derni S, Fabbri L, Masi A, Montanari L, Pasini G, Polselli A, Tonelli U, Turci P, Amadori D.

Support Care Cancer. 1997 Sep;5(5):396-401.

PMID:
9322352
36.

Socioeconomic inequalities in morbidity and mortality in western Europe.

Di Carlo A, Baldereschi M, Amaducci L.

Lancet. 1997 Aug 16;350(9076):518. No abstract available.

PMID:
9274600
37.

Analysis of apolipoprotein E, alpha1-antichymotrypsin and presenilin-1 genes polymorphisms in dementia caused by normal pressure hydrocephalus in man.

Nacmias B, Tedde A, Guarnieri BM, Petruzzi C, Ortenzi L, Serio A, Amaducci L, Sorbi S.

Neurosci Lett. 1997 Jul 4;229(3):177-80.

PMID:
9237487
38.

European health research.

Amaducci L.

Lancet. 1997 Jun 28;349(9069):1917. No abstract available.

PMID:
9235452
39.

Cell proliferation as a predictor of response to chemotherapy in metastatic breast cancer: a prospective study.

Amadori D, Volpi A, Maltoni R, Nanni O, Amaducci L, Amadori A, Giunchi DC, Vio A, Saragoni A, Silvestrini R.

Breast Cancer Res Treat. 1997 Mar;43(1):7-14.

PMID:
9065594
40.

Presenilin-1 gene intronic polymorphism in sporadic and familial Alzheimer's disease.

Sorbi S, Nacmias B, Tedde A, Forleo P, Piacentini S, Latorraca S, Amaducci L.

Neurosci Lett. 1997 Jan 31;222(2):132-4.

PMID:
9111746
41.

Technical limits in transcranial Doppler recording: inadequate acoustic windows.

Marinoni M, Ginanneschi A, Forleo P, Amaducci L.

Ultrasound Med Biol. 1997;23(8):1275-7.

PMID:
9372576
42.

Cultural issues in the clinical diagnosis of Alzheimer disease. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines.

Amaducci L, Baldereschi M, Doody R, Chandra V, Gaines AD.

Alzheimer Dis Assoc Disord. 1997;11 Suppl 3:19-21. No abstract available.

PMID:
9305509
43.

Prevalence of parkinsonism and Parkinson's disease in Europe: the EUROPARKINSON Collaborative Study. European Community Concerted Action on the Epidemiology of Parkinson's disease.

de Rijk MC, Tzourio C, Breteler MM, Dartigues JF, Amaducci L, Lopez-Pousa S, Manubens-Bertran JM, Alpérovitch A, Rocca WA.

J Neurol Neurosurg Psychiatry. 1997 Jan;62(1):10-5.

44.

Alzheimer's original patient.

Amaducci L.

Science. 1996 Oct 18;274(5286):328a. No abstract available.

PMID:
17813504
45.

Alzheimer's original patient.

Amaducci L.

Science. 1996 Oct 18;274(5286):328. No abstract available.

PMID:
8927984
46.

Apolipoprotein E and alpha1-antichymotrypsin polymorphism in Alzheimer's disease.

Nacmias B, Tedde A, Latorraca S, Piacentini S, Bracco L, Amaducci L, Guarnieri BM, Petruzzi C, Ortenzi L, Sorbi S.

Ann Neurol. 1996 Oct;40(4):678-80.

PMID:
8871590
47.

c-fos/c-jun expression and AP-1 activation in skin fibroblasts from centenarians.

Grassilli E, Bellesia E, Salomoni P, Croce MA, Sikora E, Radziszewska E, Tesco G, Vergelli M, Latorraca S, Barbieri D, Fagiolo U, Santacaterina S, Amaducci L, Tiozzo R, Sorbi S, Franceschi C.

Biochem Biophys Res Commun. 1996 Sep 13;226(2):517-23.

PMID:
8806666
48.

Medicine in Italy.

Amaducci L, Deferrari G.

Lancet. 1996 Sep 7;348(9028):680. No abstract available.

PMID:
8782764
49.

Alzheimer's disease associated with mutations in presenilin 2 is rare and variably penetrant.

Sherrington R, Froelich S, Sorbi S, Campion D, Chi H, Rogaeva EA, Levesque G, Rogaev EI, Lin C, Liang Y, Ikeda M, Mar L, Brice A, Agid Y, Percy ME, Clerget-Darpoux F, Piacentini S, Marcon G, Nacmias B, Amaducci L, Frebourg T, Lannfelt L, Rommens JM, St George-Hyslop PH.

Hum Mol Genet. 1996 Jul;5(7):985-8.

PMID:
8817335
50.

The effect of tetraethylammonium on intracellular calcium concentration in Alzheimer's disease fibroblasts with APP, S182 and E5-1 missense mutations.

Failli P, Tesco G, Ruocco C, Ginestroni A, Amaducci L, Giotti A, Sorbi S.

Neurosci Lett. 1996 Apr 26;208(3):216-8.

PMID:
8733308

Supplemental Content

Loading ...
Support Center